28th-May-2012 17:33Source: BSE

Strides Arcolab- Outcome of AGM (Clause 35A)

Strides Arcolab Ltd has informed BSE that the 21st Annual General Meeting (AGM) of the Company was held on May 25, 2012.

28th-May-2012 13:35Source: BSE

Strides Arcolab- Resignation of Director

Strides Arcolab Ltd has informed BSE that Mr. Venkat S. Iyer, CEO of Agila Specialties and Executive Director of Strides Arcolab Limited steps down as Executive Director of Strides w.e.f. May 25, 2012...

28th-May-2012 13:31Source: NSE

STRIDES ARCOLAB LIMITED Resignation of Director

Strides Arcolab Limited has informed the Exchange that Mr. Venkat S. Iyer, CEO of Agila Specialties and Executive Director of the Company steps down as Executive Director of Strides w.e.f. May 25, 201...

21st-May-2012 12:13Source: NSE

Strides Arcolab Limited

Strides Arcolab Limited has informed the Exchange that the dividend payout date will be May 30, 2012, subject to the approval of dividends by the shareholders of the Company at the ensuing Annual Gene...

19th-May-2012 13:05Source: BSE

Strides Arcolab- Dividend Payment Date

Strides Arcolab Ltd has informed BSE that the dividend payout date will be May 30, 2012, subject to the approval of dividends by the shareholders of the Company at the ensuing 21st Annual General Meet...

17th-May-2012 13:50Source: BSE

Strides Arcolab- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

HSBC Global Asset Management (Singapore) Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

10th-May-2012 16:27Source: NSE

Strides Arcolab Limited

Strides Arcolab Limited has informed the Exchange regarding a press release dated May 10, 2012, titled "Strides Arcolab Receives US FDA Approval For Acetazolamide Injection, USP"

10th-May-2012 15:24Source: BSE

Strides Arcolab- Strides Arcolab receives US FDA approval for Acetazolamide Injection, USP

Strides Arcolab Ltd has informed BSE regarding a Press Release dated May 10, 2012, titled "Strides Arcolab receives US FDA approval for Acetazolamide Injection, USP".

3rd-May-2012 12:17Source: BSE

Strides Arcolab- Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992

A K Nair has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992

3rd-May-2012 12:16Source: BSE

Strides Arcolab- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Strides Arcolab Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992